CGAS and gastric cancer: Although the WEE1 inhibitor MK1775 partly enhanced the anticancer effect of PD-L1 inhibitors by activating the cGAS/STING pathway, MUS81 targeting further amplified the anticancer effect of this combination strategy because of the elevated cytosolic dsDNA in gastric cancer cells.